S'abonner

Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction - 27/07/22

Doi : 10.1016/j.diabet.2022.101349 
Pil Sang Song a, , 1 , Kye Taek Ahn a, 1, Mi Joo Kim a, Seok-Woo Seong a, Si Wan Choi a, Hyeon-Cheol Gwon b, Seung-Ho Hur c, Seung-Woon Rha d, Chang-Hwan Yoon e, Myung Ho Jeong f, Jin-Ok Jeong a,

KAMIR-NIH Investigators

a Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Republic of Korea 
b Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea 
c Keimyung University Dongsan Medical Center, Cardiovascular Medicine, Deagu, Republic of Korea 
d Cardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea 
e Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea 
f Chonnam National University Hospital, Gwangju, Republic of Korea 

Corresponding authors at: Division of Cardiology, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea.Division of Cardiology, Department of Internal MedicineChungnam National University Hospital, Chungnam National University College of Medicine282 Munhwa-ro, Jung-guDaejeon35015Republic of Korea

Highlights

Diabetes mellitus (DM) is highly prevalent among individuals hospitalized with acute myocardial infarction (AMI) and is associated with increased risk for long-term mortality.
ü
DM is highly prevalent among individuals hospitalized with AMI and is associated with increased risk for long-term mortality.
Over a median follow-up of three years, diabetes was associated with a 32% higher all-cause mortality after adjusting for multiple covariates in the entire cohort.
ü
DM was associated with a 32% higher all-cause mortality after adjusting for multiple covariates in the entire cohort.
These findings highlight the need for more aggressive therapies aimed at preventing future adverse cardiovascular events in young patients post-AMI.
ü
These findings highlight the need for more aggressive therapies aimed at preventing future adverse cardiovascular events in young patients post-AMI.

Le texte complet de cet article est disponible en PDF.

Abstract

Aim

To test the hypothesis that the impact of diabetes mellitus on clinical outcomes after acute myocardial infarction (AMI) can vary by age.

Methods

A total of 12,600 AMI patients from the Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) between November 2011 and December 2015 was classified into young (n = 3,590 [29%]) and old (n = 9,010 [72%]). Those less than 55 years of age were considered young. We performed comparisons of baseline characteristics, in-hospital treatments, and 3-year clinical outcomes between patients with and without diabetes after stratification according to age group.

Results

The prevalence of diabetes mellitus was 27% in the young AMI group. In the multivariable adjusted model of the entire cohort, diabetes mellitus was associated strongly with 3-year all-cause mortality (13% vs. 6.8%; adjusted hazard ratio [HR], 1.318; 95% confidence interval [CI], 1.138–1.526; P<0.001). When the entire cohort was subdivided into two age groups, young diabetic patients showed a 107% higher mortality rate than those without diabetes (adjusted HR, 2.07 [1.153.72]; P = 0.015). Meanwhile, old diabetic patients had a 25% higher risk of mortality than non-diabetic patients (adjusted HR, 1.25 [1.081.46]; P = 0.004). The interaction of diabetes with age was significant (adjusted P for interaction = 0.008).

Conclusions

Diabetes mellitus is not uncommon in younger AMI patients, and the relative risk of 3-year mortality is significantly higher in young patients than in older counterparts. More aggressive treatments are needed to prevent future cardiovascular events in younger patients after AMI.

Le texte complet de cet article est disponible en PDF.

Keywords : Acute myocardial infarction, Diabetes mellitus, Age, Prognosis

List of abbreviations : AMI, CI, DM, HR, KAMIR-NIH, MACE, PCI, RAAS


Plan


© 2022  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 48 - N° 4

Article 101349- juillet 2022 Retour au numéro
Article précédent Article précédent
  • Epigenetic changes associated with hyperglycaemia exposure in the longitudinal D.E.S.I.R. cohort
  • Amna Khamis, Lijiao Ning, Beverley Balkau, Amélie Bonnefond, Mickaël Canouil, Ronan Roussel, Philippe Froguel
| Article suivant Article suivant
  • Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study
  • Anda-Petronela Radan, Mihaela-Madalina Fluri, Konstantinos Nirgianakis, Beatrice Mosimann, Bettina Schlatter, Luigi Raio, Daniel Surbek

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.